{
    "2020-11-02": [
        [
            {
                "time": "",
                "original_text": "【光大金工|调整名单预测】凯莱英、紫光国微或纳入沪深300指数成分股",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "紫光国微",
                        "沪深300",
                        "成分股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "半导体"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "疫情影響逐漸消退，關注高成長龍頭+細分冠軍 -- 医藥生物上市公司2020年三季報小結",
                "features": {
                    "keywords": [
                        "疫情",
                        "高成长",
                        "龙头",
                        "细分冠军",
                        "医药生物",
                        "三季报"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【浙商医药|三季报】創新藥研發高景氣有望持續，看好CDMO業績加速",
                "features": {
                    "keywords": [
                        "创新药",
                        "研发",
                        "高景气",
                        "CDMO",
                        "业绩加速",
                        "三季报"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}